Wemade Launched ‘GalaxyTornado on WEMIX’ On Global Market
Wemade launched a new blockchain game, ‘GalaxyTornado on WEMIX’, for the global market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211227005143/en/
Wemade launched a new blockchain game, ‘GalaxyTornado on WEMIX’, for the global market. ‘GalaxyTornado’ has been released through Google Play in the global market, North America, Europe, and Asia, excluding some countries such as South Korea and China. In ‘GalaxyTornado’, a casual game, players can explore and develop new planets for the future of a resource-deprived Earth. Easy controllability enables exploring and collecting from more planets, and a competition system among players is in place as well. To celebrate the global launching, three events will be held; the Symbol Collection Event, where Tornado and in-game items can be earned until further notice, a giveaway event where energy necessary for game-play can be earned, and Galaxy Race where players can earn Tornado according to the Rubies they earned in the race. (Graphic: Business Wire)
‘GalaxyTornado’ has been released through Google Play in the global market, North America, Europe, and Asia, excluding some countries such as South Korea and China; 15 languages including English, Spanish, and Arabic will be supported within the game.
NT Games, the company behind the new game ‘GalaxyTornado’, has rich experience in global game developing and servicing, with titles including ‘Girls' Life’, ‘Ocean Tales’, and collectible games such as ‘Goddess Kiss’ and ‘Age Of War’.
In ‘GalaxyTornado’, a casual game, players can explore and develop new planets for the future of a resource-deprived Earth. Easy controllability enables exploring and collecting from more planets, and a competition system among players is in place as well.
Every strategic element, such as building, growing, collecting, looting, competition, and cooperation is included to increase intuitive enjoyment of game-play; and players can earn Tornado Tokens in the weekly Galaxy Race.
To celebrate the global launching, three events will be held; the Symbol Collection Event, where Tornado and in-game items can be earned until further notice, and a giveaway event where energy necessary for game-play can be earned.
And after the launching, players can pay a certain amount of Tornado to participate in the Galaxy Race to earn Tornado according to the Rubies they earned in the race.
"If you want to experience P&E (Play and Earn) in the easiest way and with the clearest goal, ‘GalaxyTornado’ is the game," said NT Games. "We expect the cooperation with the WEMIX platform will maximize the virtuous cycle of the competition and reward that ‘GalaxyTornado’ wanted to achieve."
"We will try our best to gain an early foothold in the global blockchain casual game market," said Henry Chang, CEO of Wemade. "Blockchain games, based on the token economy, will have an unprecedentedly dynamic and long life cycle."
WEMIX: https://wemixnetwork.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211227005143/en/
Contact information
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com